Search research articles
Contact Us
Filters
Showing results (581-590 of 611) with videos related to
Page
of 62
Sort By:
Pharmacotherapy
|
September 12, 2023
CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial
Scott A Mosley, Emily Cicali, Alex Del Cueto, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Positive Selection Screen for Natural Product β-Catenin Inactivators
Matthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Nature
|
June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Mikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Journal of the American Chemical Society
|
June 26, 2026
A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition
Ji Hyeon Kim, Caitlin E Mills, Zuzanna Kozicka, et al.
Cancer Discovery
|
September 21, 2021
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
Qing Li, Baishan Jiang, Jiaye Guo, et al.
Nature Cancer
|
May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia
Brandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.
Nature Genetics
|
April 16, 1998
Vertebrate genome evolution and the zebrafish gene map
J H Postlethwait, Y L Yan, M A Gates, et al.
Blood
|
December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML
Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Science Advances
|
May 20, 2026
Autism-like phenotypes and increased NMDAR2D expression in mice with KDM5B histone lysine demethylase deficiency
Leticia Pérez-Sisqués, Shail U Bhatt, Angela Caruso, et al.
Medical Image Analysis
|
March 27, 2024
Domain generalization across tumor types, laboratories, and species - Insights from the 2022 edition of the Mitosis Domain Generalization Challenge
Marc Aubreville, Nikolas Stathonikos, Taryn A Donovan, et al.
Page
of 62
Search research articles
Search
Showing results (581-590 of 611) with videos related to
Sort By:
Page
of 62
Pharmacotherapy
|
September 12, 2023
CYP2D6-guided opioid therapy for adults with cancer pain: A randomized implementation clinical trial
Scott A Mosley, Emily Cicali, Alex Del Cueto, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Positive Selection Screen for Natural Product β-Catenin Inactivators
Matthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Nature
|
June 5, 2020
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K
Mikołaj Słabicki, Zuzanna Kozicka, Georg Petzold, et al.
Journal of the American Chemical Society
|
June 26, 2026
A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition
Ji Hyeon Kim, Caitlin E Mills, Zuzanna Kozicka, et al.
Cancer Discovery
|
September 21, 2021
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors
Qing Li, Baishan Jiang, Jiaye Guo, et al.
Nature Cancer
|
May 9, 2022
IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia
Brandon J Aubrey, Jevon A Cutler, Wallace Bourgeois, et al.
Nature Genetics
|
April 16, 1998
Vertebrate genome evolution and the zebrafish gene map
J H Postlethwait, Y L Yan, M A Gates, et al.
Blood
|
December 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML
Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey, et al.
Science Advances
|
May 20, 2026
Autism-like phenotypes and increased NMDAR2D expression in mice with KDM5B histone lysine demethylase deficiency
Leticia Pérez-Sisqués, Shail U Bhatt, Angela Caruso, et al.
Medical Image Analysis
|
March 27, 2024
Domain generalization across tumor types, laboratories, and species - Insights from the 2022 edition of the Mitosis Domain Generalization Challenge
Marc Aubreville, Nikolas Stathonikos, Taryn A Donovan, et al.
Page
of 62